We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$683M
AUM Growth
+$58.2M
(+9.3%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.97M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
BCPC
Balchem Corp
BCPC
|
+$2.09M |
| 4 |
Quest Diagnostics
DGX
|
+$1.56M |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.54M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.95M |
| 3 |
Comcast
CMCSA
|
+$1.76M |
| 4 |
CDW
CDW
|
+$1.48M |
| 5 |
Medtronic
MDT
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Conagra Brands
CAG
$6.94B
| $670K | 0.1% |
32,738
| – | – |
|
152
Vanguard Morningstar Value ETF
VTV
$188B
| $662K | 0.1% |
3,743
+442
| +13% | +$74.7K |
|
153
Humana
HUM
$43.7B
| $661K | 0.1% |
2,705
-759
| -22% | -$189K |
|
154
EXL Service
EXLS
$5.14B
| $654K | 0.1% |
14,930
+881
| +6% | +$40.3K |
|
155
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
| $651K | 0.1% |
4,960
| – | – |
|
156
Tetra Tech
TTEK
$8.49B
| $641K | 0.09% |
17,819
+1,052
| +6% | +$35K |
|
157
Invesco QQQ Trust
QQQ
$453B
| $632K | 0.09% |
1,146
-173
| -13% | -$86K |
|
158
Enpro
NPO
$6.63B
| $611K | 0.09% |
3,192
+475
| +17% | +$81.2K |
|
159
iShares Core S&P Small-Cap ETF
IJR
$109B
| $602K | 0.09% |
5,509
-20
| -0.4% | -$2.07K |
|
160
Carlisle Companies
CSL
$14.3B
| $601K | 0.09% |
1,610
+96
| +6% | +$35.6K |
|
161
SouthState Bank Corp
SSB
$10.2B
| $594K | 0.09% |
6,459
+382
| +6% | +$33.6K |
|
162
Dorman Products
DORM
$3.98B
| $584K | 0.09% |
4,758
+165
| +4% | +$20.1K |
|
163
Agree Realty
ADC
$9.34B
| $582K | 0.09% |
7,967
+473
| +6% | +$35.6K |
|
|
PR
164
Permian Resources
PR
$17.8B
| $560K | 0.08% |
41,133
+2,417
| +6% | +$31.1K |
|
165
Selective Insurance
SIGI
$5.65B
| $545K | 0.08% |
6,286
+370
| +6% | +$32.4K |
|
166
Moelis & Co
MC
$4.97B
| $518K | 0.08% |
8,316
+491
| +6% | +$27.6K |
|
167
Power Integrations
POWI
$3.38B
| $513K | 0.08% |
9,177
+1,539
| +20% | +$79K |
|
168
Merck
MRK
$322B
| $492K | 0.07% |
6,213
-7,387
| -54% | -$587K |
|
169
Integer Holdings
ITGR
$4.12B
| $482K | 0.07% |
3,923
+232
| +6% | +$27.7K |
|
170
Atlantic Union Bankshares
AUB
$6.02B
| $461K | 0.07% |
14,730
+3,732
| +34% | +$108K |
|
171
Qualys
QLYS
$5.1B
| $444K | 0.07% |
3,110
+183
| +6% | +$24.2K |
|
172
Enovis
ENOV
$1.68B
| $439K | 0.06% |
14,003
+2,114
| +18% | +$69.9K |
|
173
McDonald's
MCD
$192B
| $436K | 0.06% |
1,493
+20
| +1% | +$6.17K |
|
174
ICF International
ICFI
$1.46B
| $431K | 0.06% |
5,093
+301
| +6% | +$25.5K |
|
|
MZTI
175
The Marzetti Company
MZTI
$2.93B
| $425K | 0.06% |
2,460
+437
| +22% | +$75.4K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
- First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
- First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
- First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
- First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
- First National Advisers opened 14 new positions and closed 5 in Q2 2025.
- First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.
Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.